Parthenolide, Bioactive Compound of Chrysanthemum parthenium L., Ameliorates Fibrogenesis and Inflammation in Hepatic Fibrosis via Regulating the Crosstalk of TLR4 and STAT3 Signaling Pathway

Scientists focused on the regulatory effects of parthenolide, a bioactive component derived from Chrysanthemum parthenium L., against hepatic fibrosis via regulating the crosstalk of toll-like receptor 4 and signal transducer and activator of transcription 3 in activated hepatic stellate cells.